我国糖尿病视网膜病变筛查的图像采集及阅片指南(2017年)

2017-12-30 中华医学会眼科学分会 中华眼科杂志2017 年12月第53 卷第12期

2014年中华医学会眼科学分会眼底病学组撰写的《我国糖尿病视网膜病变临床诊疗指南(2014年)》作为第1版国人DR筛查、诊断和干预指南,对全科医师、眼科专科医师和眼底病专业医师的DR临床诊疗工作发挥了重要的指导作用。目前我国87%糖尿病患者就诊于眼科医疗资源极其有限的县级及以下医疗机构。部分DR流行病学调查结果显示,50%以上就诊于基层医疗机构的糖尿病患者未被告知应定期进行眼底检查,近70%糖尿病

中文标题:

我国糖尿病视网膜病变筛查的图像采集及阅片指南(2017年)

发布日期:

2017-12-30

简要介绍:

2014年中华医学会眼科学分会眼底病学组撰写的《我国糖尿病视网膜病变临床诊疗指南(2014年)》作为第1版国人DR筛查、诊断和干预指南,对全科医师、眼科专科医师和眼底病专业医师的DR临床诊疗工作发挥了重要的指导作用。目前我国87%糖尿病患者就诊于眼科医疗资源极其有限的县级及以下医疗机构。部分DR流行病学调查结果显示,50%以上就诊于基层医疗机构的糖尿病患者未被告知应定期进行眼底检查,近70%糖尿病患者未接受规范的眼科检查。由此可见,我国糖尿病患者视网膜病变的筛查和有效转诊工作面临巨大的挑战。

 

拓展指南:糖尿病相关指南:

下载附件:

(因为版权问题,不支持下载)

评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1010268, encodeId=4b6a1010268a6, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210404/0afb6552256941dca427875c6ac1c03d/732ab26b4f4344bf95b815a3861c024d.jpg, createdBy=04cd2205775, createdName=段正太, createdTime=Sun Aug 22 11:19:05 CST 2021, time=2021-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903841, encodeId=3c0690384144, content=多谢,写字了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e51d5440224, createdName=ms5000000813337645, createdTime=Tue Dec 01 12:15:12 CST 2020, time=2020-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=317487, encodeId=cf1931e4875d, content=谢谢分享.学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=40c92361602, createdName=122d198cm13暂无昵称, createdTime=Tue May 22 09:48:16 CST 2018, time=2018-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=281135, encodeId=6696281135dd, content=谢谢.学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad4c106013, createdName=Drhzm308, createdTime=Tue Jan 23 06:32:58 CST 2018, time=2018-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=281134, encodeId=edb8281134c1, content=啦啦啦啦啦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad4c106013, createdName=Drhzm308, createdTime=Tue Jan 23 06:32:50 CST 2018, time=2018-01-23, status=1, ipAttribution=)]
    2021-08-22 段正太

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1010268, encodeId=4b6a1010268a6, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210404/0afb6552256941dca427875c6ac1c03d/732ab26b4f4344bf95b815a3861c024d.jpg, createdBy=04cd2205775, createdName=段正太, createdTime=Sun Aug 22 11:19:05 CST 2021, time=2021-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903841, encodeId=3c0690384144, content=多谢,写字了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e51d5440224, createdName=ms5000000813337645, createdTime=Tue Dec 01 12:15:12 CST 2020, time=2020-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=317487, encodeId=cf1931e4875d, content=谢谢分享.学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=40c92361602, createdName=122d198cm13暂无昵称, createdTime=Tue May 22 09:48:16 CST 2018, time=2018-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=281135, encodeId=6696281135dd, content=谢谢.学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad4c106013, createdName=Drhzm308, createdTime=Tue Jan 23 06:32:58 CST 2018, time=2018-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=281134, encodeId=edb8281134c1, content=啦啦啦啦啦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad4c106013, createdName=Drhzm308, createdTime=Tue Jan 23 06:32:50 CST 2018, time=2018-01-23, status=1, ipAttribution=)]
    2020-12-01 ms5000000813337645

    多谢,写字了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1010268, encodeId=4b6a1010268a6, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210404/0afb6552256941dca427875c6ac1c03d/732ab26b4f4344bf95b815a3861c024d.jpg, createdBy=04cd2205775, createdName=段正太, createdTime=Sun Aug 22 11:19:05 CST 2021, time=2021-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903841, encodeId=3c0690384144, content=多谢,写字了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e51d5440224, createdName=ms5000000813337645, createdTime=Tue Dec 01 12:15:12 CST 2020, time=2020-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=317487, encodeId=cf1931e4875d, content=谢谢分享.学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=40c92361602, createdName=122d198cm13暂无昵称, createdTime=Tue May 22 09:48:16 CST 2018, time=2018-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=281135, encodeId=6696281135dd, content=谢谢.学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad4c106013, createdName=Drhzm308, createdTime=Tue Jan 23 06:32:58 CST 2018, time=2018-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=281134, encodeId=edb8281134c1, content=啦啦啦啦啦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad4c106013, createdName=Drhzm308, createdTime=Tue Jan 23 06:32:50 CST 2018, time=2018-01-23, status=1, ipAttribution=)]
    2018-05-22 122d198cm13暂无昵称

    谢谢分享.学习学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1010268, encodeId=4b6a1010268a6, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210404/0afb6552256941dca427875c6ac1c03d/732ab26b4f4344bf95b815a3861c024d.jpg, createdBy=04cd2205775, createdName=段正太, createdTime=Sun Aug 22 11:19:05 CST 2021, time=2021-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903841, encodeId=3c0690384144, content=多谢,写字了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e51d5440224, createdName=ms5000000813337645, createdTime=Tue Dec 01 12:15:12 CST 2020, time=2020-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=317487, encodeId=cf1931e4875d, content=谢谢分享.学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=40c92361602, createdName=122d198cm13暂无昵称, createdTime=Tue May 22 09:48:16 CST 2018, time=2018-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=281135, encodeId=6696281135dd, content=谢谢.学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad4c106013, createdName=Drhzm308, createdTime=Tue Jan 23 06:32:58 CST 2018, time=2018-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=281134, encodeId=edb8281134c1, content=啦啦啦啦啦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad4c106013, createdName=Drhzm308, createdTime=Tue Jan 23 06:32:50 CST 2018, time=2018-01-23, status=1, ipAttribution=)]
    2018-01-23 Drhzm308

    谢谢.学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1010268, encodeId=4b6a1010268a6, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210404/0afb6552256941dca427875c6ac1c03d/732ab26b4f4344bf95b815a3861c024d.jpg, createdBy=04cd2205775, createdName=段正太, createdTime=Sun Aug 22 11:19:05 CST 2021, time=2021-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903841, encodeId=3c0690384144, content=多谢,写字了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e51d5440224, createdName=ms5000000813337645, createdTime=Tue Dec 01 12:15:12 CST 2020, time=2020-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=317487, encodeId=cf1931e4875d, content=谢谢分享.学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=40c92361602, createdName=122d198cm13暂无昵称, createdTime=Tue May 22 09:48:16 CST 2018, time=2018-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=281135, encodeId=6696281135dd, content=谢谢.学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad4c106013, createdName=Drhzm308, createdTime=Tue Jan 23 06:32:58 CST 2018, time=2018-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=281134, encodeId=edb8281134c1, content=啦啦啦啦啦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad4c106013, createdName=Drhzm308, createdTime=Tue Jan 23 06:32:50 CST 2018, time=2018-01-23, status=1, ipAttribution=)]
    2018-01-23 Drhzm308

    啦啦啦啦啦

    0